comparemela.com
Home
Live Updates
Synklino completes Series A raise of EUR 29.8 million to adv
Synklino completes Series A raise of EUR 29.8 million to adv
Synklino completes Series A raise of EUR 29.8 million to advance clinical trials of its drug candidate for the treatment of Cytomegalovirus (CMV)
/PRNewswire/ -- Synklino, an emerging biotech company developing breakthrough drugs for the treatment of chronic viral infections, has completed a Series A...
Related Keywords
Sweden ,
Denmark ,
Copenhagen ,
Køavn ,
Danish ,
Swedish ,
Michael Nellemann Pedersen ,
Thomas Kledal ,
John Haurum ,
Bioinnovation Institute ,
University Of Copenhagen ,
European Investment Fund ,
Danish Growth Fund ,
Novo Holdings ,
Technical University Of Denmark ,
Chief Executive Officer ,
Nellemann Pedersen ,
Chief Investment Officer ,
Keir Ventures ,
Technical University ,
Creation House ,
Maj Invest ,
Asset Management ,
Invest Equity ,
Private Equity ,
Nordic Biotech ,
Swedish Alternative Investment Funds Managers ,
Synklino ,